IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
Houillier, C., Wang, X., Kaloshi, G., Mokhtari, K., Guillevin, R., Laffaire, J., Paris, S., Boisselier, B., Idbaih, A., Laigle-Donadey, F., Hoang-Xuan, K., Sanson, M., Delattre, J.- Y.Volume:
75
Language:
english
Journal:
Neurology
DOI:
10.1212/WNL.0b013e3181f96282
Date:
October, 2010
File:
PDF, 437 KB
english, 2010